Fig. 9. CB6 treatment on an MPTP mouse model of Parkinson’s disease (PD).

a Drug treatment and behavioral study scheme with C57BL/6 mice. MPTP was injected intraperitoneally (i.p.) for 7 consecutive days. CB6 was orally administered for 21 consecutive days and the first administration was 7 days before MPTP first injection. After all treatment, the mice were subjected to behavioral tests. b Mice weights were measured every two days. c Rotarod was chosen for mice behavioral tests and the latency to fall was recorded. Data were quantified as mean ± SEM (n = 7–9). *P < 0.05 vs. MPTP group.